FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup an... by Cremolini, Chiara, MD, Loupakis, Fotios, PhD, Antoniotti, Carlotta, MD, Lupi, Cristiana, BSc, Sensi, Elisa, PhD, Lonardi, Sara, MD, Mezi, Silvia, MD, Tomasello, Gianluca, MD, Ronzoni, Monica, MD, Zaniboni, Alberto, MD, Tonini, Giuseppe, Prof, Carlomagno, Chiara, PhD, Allegrini, Giacomo, MD, Chiara, Silvana, MD, D'Amico, Mauro, MD, Granetto, Cristina, MD, Cazzaniga, Marina, MD, Boni, Luca, MD, Fontanini, Gabriella, Prof, Falcone, Alfredo, Prof

Get full text